VVOS
Vivos Therapeutics, Inc.
Medical Devices · Healthcare · United States
0.11
close · 2026-10-30
value
4
cheaper than peers4
quality
23
stronger fundamentals23
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.18× | 98 |
| cash flow yield, latest year | -460.3% | 1 |
| cash flow yield, 1 year ago | -346.7% | 1 |
| cash flow yield, 2 years ago | -333.3% | 1 |
| cash flow yield, 3 years ago | -536.3% | 1 |
5 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 34.9% | 93 |
| operating margin | -93.6% | 17 |
| return on equity | -8585.3% | 1 |
3 of 4 measures available
Facts
| market cap | $4M |
| free cash flow | -$7.4M |
| employees | 268 |
| first trade | 2020-12-11 |
| next earnings | 2026-08-14 |
| fundamentals updated | 2026-08-18 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -2.07 | -2.22 | -11.14 | -25.90 | not reported |
| free cash flow | -$17.6M | -$13.3M | -$12.7M | -$20.5M | not reported |
| net income | -$21.2M | -$11.1M | -$13.6M | -$23.8M | not reported |
| revenue | $17.4M | $15.0M | $13.8M | $16.0M | not reported |
| unusual items | not reported | not reported | $3.8M | $1.3M | -$911,000 |